Pyrimidine Synthesis Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Pyrimidine Synthesis Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sola Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209677-001 | Jun 17, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Accord Hlthcare | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209690-001 | Jan 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Amneal Pharms Co | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209613-001 | Sep 28, 2018 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209668-001 | Nov 30, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Accord Hlthcare | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209690-002 | Jan 7, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Zydus Pharms | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209668-002 | Nov 30, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Hetero Labs Ltd V | TERIFLUNOMIDE | teriflunomide | TABLET;ORAL | 209598-001 | Mar 13, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
